GOSS
Gossamer Bio Inc
10.80$
+1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -28,825.0% | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +940.1% | +38.2% | +21.1% | -14.3% | -1.0% | -5.3% | -75.9% | |
| – | – | +96,609.4% | -32.7% | +86.1% | -17.4% | +32.9% | -33.0% | -27.7% | -48.8% | |
| – | +0.0% | +251,793.8% | -74.2% | +85.1% | -16.8% | +32.9% | – | – | – | |
| – | +865.0% | +1,411.3% | -32.6% | -130.6% | – | -676.1% | – | – | -134.5% | |
| – | +0.0% | +507.8% | -69.0% | +279.0% | -93.5% | -70.7% | -100.0% | – | – | |
| – | +0.0% | +0.0% | +1.7% | – | -154.5% | -99.1% | +10,621.7% | – | +438.7% | |
| – | – | – | -3.2% | -59.9% | -97.2% | +3,591.7% | -99.6% | +41.7% | – | |
| – | +14,900.0% | -100.7% | – | +586.0% | -103.0% | +0.0% | +100.0% | +8.3% | -100.0% | |
| – | +14,900.0% | +4,914.3% | +6.9% | -2.8% | -98.9% | +3,417.3% | +62.4% | -106.0% | – | |
| – | – | +41,117.3% | -71.8% | +1,084.8% | -186.2% | – | – | – | -159.7% | |
| – | -28,825.0% | – | – | – | – | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.